INVESTOR ALERT: Ademi & O'Reilly, LLP Investigates Whether Johnson & Johnson (JNJ) Violated Securities Laws

Saturday, December 15, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

MILWAUKEE, Dec. 14, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces an investigation of Johnson & Johnson (NYSE:

JNJ) for possible violations of securities laws.

If you lost money on your J & J investment, you are encouraged to contact us at: http://ademilaw.com/case/j-j or call Guri Ademi toll-free at 866-264-3995. 

There is no cost to you.

The investigation focuses on whether J & J violated securities laws by failing to tell investors that its raw talc and finished powders tested positive for asbestos, and that J & J executives knew about the problem but failed to disclose it to regulators or the public.  Specifically, according to reports based on J & J's internal documents, J & J's Baby Powder and Shower to Shower talc, longtime brands, may have been linked to ovarian cancer.

If you lost money on your J & J investment and want additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or http://ademilaw.com/case/j-j.

Ademi & O'Reilly, LLP specializes in protecting investor rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & O'Reilly, LLPGuri AdemiToll Free: (866) 264-3995Fax: (414) 482-8001

 

Cision View original content:http://www.prnewswire.com/news-releases/investor-alert-ademi--oreilly-llp-investigates-whether-johnson--johnson-jnj-violated-securities-laws-300765829.html

SOURCE Ademi & O'Reilly, LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store